No Data
Revenues Tell The Story For Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. (SZSE:300937) As Its Stock Soars 34%
Yiyigou (300937.SZ): plans to invest in Xinhua Chain through a capital increase and share expansion.
On November 22, Gelonghui reported that Yaoyigou (300937.SZ) announced that in order to promote cooperation in the pharmaceutical industry, jointly expand market scale, and enhance market influence, the company's wholly-owned subsidiary Sichuan Yaoyigou Technology Group Co., Ltd. (referred to as "Yaoyigou Technology") signed an "Investment Agreement on Chongqing Xinhua Pharmacy Chain Co., Ltd." with Chongqing Xinhua Pharmacy Chain Co., Ltd. (referred to as "Xinhua Chain" or "target company"), Chongqing Haihu Group Co., Ltd., Mr. Zhang Yuehong, Ms. Luo Yuqin, and Ms. Zhang Peiyue. Yaoyigou Technology plans to invest 150 million yuan of its own funds at a post-investment valuation of 0.3 billion yuan.
Weak Statutory Earnings May Not Tell The Whole Story For Sichuan Hezong Medicine Easy-to-buy Pharmaceutical (SZSE:300937)
Medicago: Report for the third quarter of 2024
PharmEasy (300937.SZ) released its performance for the first three quarters, with a net income of 13.9315 million yuan, a 72.22% decrease year-on-year.
Pharmacy Easy Purchase (300937.SZ) released the third quarter report of 2024, with revenue of 32...
PharmacyEasy (300937.SZ): The net income in the first three quarters was 13.9315 million yuan, a year-on-year decrease of 72.22%.
格隆汇October 24th丨Pharmacy Easy Purchase (300937.SZ) announced the third quarter report of 2024, with the company's revenue for the first three quarters reaching 3.235 billion yuan, a year-on-year increase of 0.72%; net income attributable to shareholders of the listed company was 13.9315 million yuan, a year-on-year decrease of 72.22%; net income attributable to shareholders of the listed company excluding non-recurring gains and losses was 9.3653 million yuan, a year-on-year decrease of 80.09%; basic earnings per share was 0.15 yuan.
No Data
